Document is current
Any future updates will be listed below
-
Authors
Leon, Celine
Odou, Marie-Françoise
Roquelaure, Bertrand
Lebreton, Louis
Ruiz, Mathias
Schneider, Carolin Victoria
Renoux, Celine
Evrard, Aurélie
Balduyck, Malika
Dechomet, Magali
Lombard, Christine
Butori-Pepino, Mathilde
Schneider, Kai Markus
Marin, Victor
di-Tomasso, Sylvaine
Dourthe, Cyril
Dupuy, Jean-William
Raymond, Anne-Aurélie
Collardeau-Frachon, Sophie
Haffner, Aurélie
Fritih, Radia
Goubert, Emmanuelle
Geromel, Vanna
Joly, Philippe
Fabre, Alexandre
Bouchecareilh, Marion https://orcid.org/0000-0001-9233-4152
- License Information
-
More Information
Article History
Received: 15 May 2025
Accepted: 4 November 2025
First Online: 21 November 2025
Declarations
:
: Human samples were obtained from the “Tissu-Tumorothèque Est, CRB-HCL” and “AP-HM Hôpital de la Timone” according to standard protocols and written informed consent was obtained from all participants or their legal guardians included in the study. Pediatric liver control samples were obtained from patients with diagnoses of oxalosis. The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the institution’s human research committee. Regarding the UK Biobank (UKB), this study was approved by the North West Multi-centre Research Ethics Committee (REC reference: 16/NW/0274) under the UKB access number 71,300.
: Human samples were obtained from the “Tissu-Tumorothèque Est, CRB-HCL” and “AP-HM Hôpital de la Timone” according to standard protocols and written informed consent was obtained from all participants or their legal guardians included in the study.
: Mathias Ruiz received consulting and lecture fees from Takeda Pharmaceuticals and CSL Behring. Mathias Ruiz and Marion Bouchecareilh received consulting fees from Grifols Inc.
